Page last updated: 2024-11-01

omeprazole and Intestinal Neoplasms

omeprazole has been researched along with Intestinal Neoplasms in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Intestinal Neoplasms: Tumors or cancer of the INTESTINES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dingemanse, C1
Belzer, C1
van Hijum, SA1
Günthel, M1
Salvatori, D1
den Dunnen, JT1
Kuijper, EJ1
Devilee, P1
de Vos, WM1
van Ommen, GB1
Robanus-Maandag, EC1

Other Studies

1 other study available for omeprazole and Intestinal Neoplasms

ArticleYear
Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice.
    Carcinogenesis, 2015, Volume: 36, Issue:11

    Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Carcinogenesis; Clarithromycin; Drug Therapy, Combinati

2015